Biology of Senescent Liver Peroxisomes: Role in Hepatocellular Aging and Disease

Overview

Journal Environ Health Perspect

Date 1999 Sep 30

PMID 10504144

Citations 12

Authors

J Youssef

M Badr

Affiliations

Soon will be listed here.

Abstract

Despite rising interest in the health problems of the elderly, information on senescence-related alterations in essential metabolic pathways and their responses to various chemicals is scarce. Although peroxisomal pathways are involved in a multitude of cellular functions, little attention has been given to the potential relationship between senescence of these organelles and the process of aging and disease. Although the prevailing experimental evidence points to a decline in liver peroxisomal enzyme activities and a muted response to peroxisome-proliferating chemicals in aged animals, it is also evident that aged animals are more susceptible, in comparison to their young counterparts, to the hepatocarcinogenic effects of these chemicals. Furthermore, little is known about extraperoxisomal effects of peroxisome proliferators in aged animals. This review evaluates published studies on the impact of aging on basal hepatic peroxisomal metabolism, response to peroxisome proliferators, and changes in signal transduction pathways involved in these processes, with the aim of stimulating research efforts in this important area. The potential intricate relationship among senescent peroxisomes, aged hepatocytes, and health are also discussed.

Citing Articles

Rise and fall of peroxisomes during Alzheimer´s disease: a pilot study in human brains.

Semikasev E, Ahlemeyer B, Acker T, Schanzer A, Baumgart-Vogt E Acta Neuropathol Commun. 2023; 11(1):80.

PMID: 37170361 PMC: 10176950. DOI: 10.1186/s40478-023-01567-0.

Determinants of gene expression in the human liver: Impact of aging and sex on xenobiotic metabolism.

Corton J, Lee J, Liu J, Ren H, Vallanat B, Devito M Exp Gerontol. 2022; 169:111976.

PMID: 36244585 PMC: 10586520. DOI: 10.1016/j.exger.2022.111976.

Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions.

Pergialiotis V, Frountzas M, Fasoulakis Z, Daskalakis G, Chrisochoidi M, Kontzoglou K Cureus. 2022; 14(2):e22616.

PMID: 35371629 PMC: 8958147. DOI: 10.7759/cureus.22616.

Activation of Peroxisome Proliferator-Activated Receptor Alpha Improves Aged and UV-Irradiated Skin by Catalase Induction.

Shin M, Lee S, Kim M, Shin C, Lee D, Chung J PLoS One. 2016; 11(9):e0162628.

PMID: 27611371 PMC: 5017777. DOI: 10.1371/journal.pone.0162628.

Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.

Astarita G, Piomelli D Prostaglandins Leukot Essent Fatty Acids. 2011; 85(5):197-203.

PMID: 21543199 PMC: 3161165. DOI: 10.1016/j.plefa.2011.04.021.

References

Horie S, Ishii H, Suga T . Changes in peroxisomal fatty acid oxidation in the diabetic rat liver. J Biochem. 1981; 90(6):1691-6. DOI: 10.1093/oxfordjournals.jbchem.a133645. View

Fringes B, Reith A . Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism in rat liver: a morphometric/stereologic study by electron microscopy. Lab Invest. 1982; 47(1):19-26. View

de la Iglesia F, Lewis J, Buchanan R, Marcus E, McMahon G . Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis. 1982; 43(1):19-37. DOI: 10.1016/0021-9150(82)90096-x. View

SCHAPIRO H, HOTTA S, Outten W, Klein A . The effect of aging on rat liver regeneration. Experientia. 1982; 38(9):1075-6. DOI: 10.1007/BF01955375. View

Perichon R, Bourre J . Peroxisomal beta-oxidation activity and catalase activity during development and aging in mouse liver. Biochimie. 1995; 77(4):288-93. DOI: 10.1016/0300-9084(96)88138-7. View

Diehl A, RAI R . Liver regeneration 3: Regulation of signal transduction during liver regeneration. FASEB J. 1996; 10(2):215-27. DOI: 10.1096/fasebj.10.2.8641555. View

OBrien M, Rangwala S, Henry K, Weinberger C, Crick D, Waechter C . Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis. Carcinogenesis. 1996; 17(2):185-90. DOI: 10.1093/carcin/17.2.185. View

Miller R, Glover S, STEWART W, Corton J, Popp J, Cattley R . Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643. Carcinogenesis. 1996; 17(6):1337-41. DOI: 10.1093/carcin/17.6.1337. View

Perichon R, Bourre J . Aging-related decrease in liver peroxisomal fatty acid oxidation in control and clofibrate-treated mice. A biochemical study and mechanistic approach. Mech Ageing Dev. 1996; 87(2):115-26. DOI: 10.1016/0047-6374(96)01705-8. View

10.

Devchand P, Keller H, Peters J, Vazquez M, Gonzalez F, Wahli W . The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 1996; 384(6604):39-43. DOI: 10.1038/384039a0. View

11.

Tontonoz P, Singer S, Forman B, Sarraf P, Fletcher J, Fletcher C . Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A. 1997; 94(1):237-41. PMC: 19300. DOI: 10.1073/pnas.94.1.237. View

12.

Singh I . Biochemistry of peroxisomes in health and disease. Mol Cell Biochem. 1997; 167(1-2):1-29. DOI: 10.1023/a:1006883229684. View

13.

Forman B, Chen J, Evans R . Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A. 1997; 94(9):4312-7. PMC: 20719. DOI: 10.1073/pnas.94.9.4312. View

14.

Kliewer S, Sundseth S, Jones S, Brown P, Wisely G, Koble C . Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A. 1997; 94(9):4318-23. PMC: 20720. DOI: 10.1073/pnas.94.9.4318. View

15.

Warner H . Aging and regulation of apoptosis. Curr Top Cell Regul. 1997; 35:107-21. DOI: 10.1016/s0070-2137(97)80004-0. View

16.

Soliman M, Cunningham M, Morrow J, Roberts 2nd L, Badr M . Evidence against peroxisome proliferation-induced hepatic oxidative damage. Biochem Pharmacol. 1997; 53(9):1369-74. DOI: 10.1016/s0006-2952(97)87956-7. View

17.

Rubin H . Cell aging in vivo and in vitro. Mech Ageing Dev. 1997; 98(1):1-35. DOI: 10.1016/s0047-6374(97)00067-5. View

18.

Roth G . Age changes in signal transduction and gene expression. Mech Ageing Dev. 1997; 98(3):231-8. DOI: 10.1016/s0047-6374(97)00110-3. View

19.

Roberts R, James N, Woodyatt N, Macdonald N, Tugwood J . Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis. 1998; 19(1):43-8. DOI: 10.1093/carcin/19.1.43. View

20.

Mukherjee R, Strasser J, Jow L, Hoener P, Paterniti Jr J, HEYMAN R . RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol. 1998; 18(2):272-6. DOI: 10.1161/01.atv.18.2.272. View